Mitral regurgitation and cardiac resynchronization therapy.

Area of Science:

• Cardiology
• Cardiac Electrophysiology
• Heart Failure Management

Background:

• Secondary mitral regurgitation (MR) is common in patients with severely depressed left ventricular (LV) function, significantly increasing mortality and reducing exercise capacity.
• Key mechanisms include papillary muscle displacement, mitral annular dilatation, and impaired LV contraction, all exacerbated by LV remodeling and mechanical dyssynchrony.

Purpose of the Study:

• To evaluate the efficacy of cardiac resynchronization therapy (CRT) as a therapeutic option for secondary MR.
• To assess the impact of CRT on both systolic and diastolic components of secondary MR and identify patient subgroups most likely to benefit.

Main Methods:

• Analysis of CRT effects on secondary MR, considering both acute and long-term outcomes.
• Assessment of hemodynamic changes, including alterations in closing and tethering forces on the mitral valve.
• Identification of patient characteristics (e.g., MR severity, etiology, QRS duration, rhythm) associated with CRT response.

Main Results:

• CRT significantly reduces systolic MR by 30-40% at rest and during exercise and abolishes diastolic MR.
• CRT improves LV reverse remodeling, increases mitral valve closing forces, and decreases tethering forces.
• Patient selection criteria include moderate-to-severe MR of nonischemic origin with significant interpapillary muscle dyssynchrony.

Conclusions:

• Cardiac resynchronization therapy is an effective treatment for secondary MR in patients with systolic heart failure and mechanical dyssynchrony.
• CRT offers both acute and long-term benefits by improving LV function and mitigating MR mechanisms.
• Biventricular pacing is the preferred modality, with consistent benefits across various rhythms and QRS durations if dyssynchrony is present.